Dexmecamylamine

DB11807InvestigationalSmall moleculeAutonomic Ganglionic Blocker

Dexmecamylamine has been used in trials studying the basic science and treatment of Patients, Depression, Drug Abuse, Pharmacokinetics, and Renal Impairment, among others.

Formula / weight: C₁₁H₂₁N · 167.296 g/mol (avg)
Code names: TC-5214

Resolves to

Compound

UNII5Y1141YI4UCAS107538-05-6ChEMBLCHEMBL2103881PubChem12358972

Structure

InChIKeyIMYZQPCYWPFTAG-NGZCFLSTSA-NSMILESCN[C@@]1(C)[C@@H]2CC[C@@H](C2)C1(C)C

Targets

P17787CHRNB2

What you can answer from here — as of September 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

16Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Dexmecamylamine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account